Dr. Reddy's Laboratory To Distribute Russian Vaccine In India

Pharmaceutical Dr. Reddy's Laboratory has entered into an agreement with the Russian Direct Investment Fund for conducting Phase III clinical trials of the Sputnik V in India, The Hyderabad-based pharma company will also manufacture 100 million doses of the Russian vaccine. 

Russia approved the use of the vaccine on August 11 and its findings were published in the medical journal Lancet on September 4. The country is the fourth worst affected nation while India is the second worst affected nation. 

Details about the phases III trials and the financial deal have not been shared by either of the two parties.